NCT00806858View on ClinicalTrials.gov

Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus

CompletedOBSERVATIONAL

Enrollment

526

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Delivery Systems

Interventions

DEVICE

NovoPen® 4

Insulin administration by means of a NovoPen® 4 pen device

Trial Locations (1)

100004

Novo Nordisk Investigational Site, Beijing

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY